This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
| Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of a film-coated tablet, using a "specified substance"
{
"resourceType": "Ingredient",
"id": "example",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>role</b>: <span>ActiveBase</span></p><p><b>manufacturer</b>: <a>Organization/example</a></p><blockquote><p><b>specifiedSubstance</b></p><h3>Codes</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table><p><b>group</b>: <span>2</span></p></blockquote><blockquote><p><b>specifiedSubstance</b></p><h3>Codes</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table><p><b>group</b>: <span>2</span></p></blockquote></div>"
},
"role": {
"coding": [
{
"system": "http://ema.europa.eu/example/ingredientRole",
"code": "ActiveBase"
}
]
},
"manufacturer": [
{
"reference": "Organization/example"
}
],
"specifiedSubstance": [
{
"code": {
"concept": {
"coding": [
{
"system": "http://ema.europa.eu/example/specifiedSubstance",
"code": "equixabanCompany1"
}
]
}
},
"group": {
"coding": [
{
"system": "http://ema.europa.eu/example/specifiedSubstanceGroup",
"code": "2"
}
]
}
},
{
"code": {
"concept": {
"coding": [
{
"system": "http://ema.europa.eu/example/specifiedSubstance",
"code": "equixabanCompany2"
}
]
}
},
"group": {
"coding": [
{
"system": "http://ema.europa.eu/example/specifiedSubstanceGroup",
"code": "2"
}
]
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.